XML 33 R21.htm IDEA: XBRL DOCUMENT v3.5.0.2
Stockholders' Equity and Redeemable Convertible Preferred Stock (Tables)
6 Months Ended
Jun. 30, 2016
Stockholders' Equity Note [Abstract]  
Schedule of designated separate series of capital stock

The Company had designated separate series of its capital stock as of June 30, 2016 and December 31, 2015 as summarized below:

 

    Number of Shares Issued            
    and Outstanding as of            
    June 30,
2016
    December 31,
2015
    Par Value     Conversion Ratio
Series "A"     -       -     $ 0.0001     N/A
Series "C"     -       -       0.0001     0.05:1
Series “D"     4,725       4,725       0.0001     0.53:1
Series “D-1"     834       834       0.0001     0.53:1
Series “F-1"     -       -       0.0001     0.05:1
Series “H"     -       381,967       0.0001     0.53:1
Series “I”     -       -       0.0001     1.05:1
Series “J”     -       -       0.0001     0.05:1
Series “K”     -       1,240       0.0001     263.16:1
Schedule of warrant activity

A summary of warrant activity for the six months ended June 30, 2016 is presented below:

 

    Warrants     Weighted Average
Exercise Price
    Total Intrinsic
Value
    Weighted Average
Remaining Contractual 
Life 
(in years)
 
Outstanding as of December 31, 2015     2,304,888     $ 7.98     $ -       2.83  
Exercised     (200,000 )     3.80                  
Expired     (853,179 )                     -  
Outstanding as of June 30, 2016     1,251,709     $ 10.15               4.42  
Exercisable as of June 30, 2016     1,251,709     $ 10.15     $ -       4.42  
Schedule of option activity

A summary of option activity under the Company’s employee stock option plan for the six months ended June 30, 2016 is presented below:

 

    Number of Shares     Weighted Average
Exercise Price
    Total Intrinsic Value     Weighted Average
Remaining Contractual 
Life (in years)
 
Outstanding as of December 31, 2015     286,487     $ 89.07     $ -       5.0  
Employee options granted     19,735       1.98       7,894       4.8  
Outstanding as of June 30, 2016     306,222     $ 83.46     $ 7,894       4.6  
Options vested and expected to vest     306,222     $ 83.46     $ 7,894       4.6  
Options vested and exercisable     294,384     $ 86.72     $ 3,948       4.6  

 

A summary of option activity under the Company’s non-employee stock option plan for the six months ended June 30, 2016 is presented below:

 

    Number of
Shares
    Weighted Average 
Exercise Price
    Total Intrinsic Value     Weighted Average
Remaining Contractual 
Life (in years)
 
Outstanding as of December 31, 2015     2,893     $ 98.07     $ -       5.4  
Non-employee options granted     -       -       -       -  
Outstanding as of June 30, 2016     2,893     $ 98.07     $ -       4.9  
Options vested and expected to vest     2,893     $ 98.07     $ -       4.9  
Options vested and exercisable     2,893     $ 98.07     $ -       4.9  
Schedule of restricted stock award activity

A summary of the restricted stock award activity for the six months ended June 30, 2016 is as follows:

 

    Number of Units     Weighted Average
Grant Day Fair Value
 
Nonvested at December 31, 2015     -     $ -  
Granted     164,113       2.20  
Vested     (164,113 )     2.20  
Nonvested at June 30, 2016     -     $ -  
Schedule of restricted stock units activity

A summary of the restricted stock award activity for the six months ended June 30, 2016 is as follows:

 

    Number of Units     Weighted Average
Grant Day Fair Value
 
Nonvested at December 31, 2015     -     $ -  
Granted     118,512       2.20  
Vested     -       -  
Nonvested at June 30, 2016     118,512     $ 2.20  
Schedule of stock-based compensation

Stock-based compensation for the six months ended June 30, 2016 and 2015 was comprised of the following ($ in thousands):

 

    For the Three Months Ended June 30,     For the Six Months Ended June 30,  
    2016     2015     2016     2015  
Employee restricted stock awards   $ -     $ -     $ -     $ 11  
Employee restricted stock units     23       -       23       -  
Employee stock option awards     19       14       21       90  
Non-employee restricted stock awards     125       33       255       33  
Total compensation expense   $ 167     $ 47     $ 299     $ 134